IO Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '26 Jun 5, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Cap	1	61	124	66	184	-
Market Cap Growth	-99.25%	-51.06%	86.88%	-64.06%	-	-
Enterprise Value	-11.96	1.78	-17.5	-74.04	-27.11	0
PB Ratio	0.65	1.29	0.93	0.48	0.87	-
P/TBV Ratio	0.62	1.29	0.62	0.48	0.13	-
EV/EBITDA Ratio	-	-	0.19	1.04	0.66	-
EV/EBIT Ratio	-	-	0.19	1.04	0.66	-
EV/FCF Ratio	0.15	-	0.24	1.23	0.66	-
Debt / Equity Ratio	19.02	0.03	0.01	0.02	0	0
Net Debt / Equity Ratio	-13.77	-1.24	-1.06	-1.01	-1.00	0.10
Net Debt / EBITDA Ratio	0.14	0.62	1.55	1.97	5.13	0.34
Net Debt / FCF Ratio	0.16	0.71	1.95	2.31	5.19	0.34
Quick Ratio	1.67	3.08	9.11	13.36	20.53	1.12
Current Ratio	2.01	3.33	9.37	13.88	21.52	1.85
Return on Equity (ROE)	-368.69%	-106.00%	-63.29%	-40.74%	-76.86%	34.11%
Return on Assets (ROA)	-169.18%	-88.49%	-61.06%	-38.88%	-36.22%	-179.46%
Return on Invested Capital (ROIC)	942.14%	1036.99%	2177.46%	29441.08%	23585.91%	1264.96%
Return on Capital Employed (ROCE)	-263.54%	-103.90%	-66.23%	-40.45%	-38.43%	-389.74%
Buyback Yield / Dilution	-0.31%	-51.31%	-51.10%	-564.62%	-2346.74%	-
Total Shareholder Return	-0.31%	-51.31%	-51.10%	-564.62%	-2346.74%	-